Pharmaceutical Sector Stabilizes Amid Geopolitical Turmoil
Eli Lilly has seen profits more than double as revenue from its weight-loss and diabetes portfolio, specifically Zepbound and Mounjaro, surges. The pharmaceutical giant reported a 43% increase in fourth-quarter ... Read More